# FDA Inspection 1216199 - STA Pharmaceutical Switzerland SA - June 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/sta-pharmaceutical-switzerland-sa/e859c5f9-d4a8-4a53-964a-616cb2b4b3a3
Source feed: FDA_Inspections

> FDA Inspection 1216199 for STA Pharmaceutical Switzerland SA on June 30, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1216199
- Company Name: STA Pharmaceutical Switzerland SA
- Inspection Date: 2023-06-30
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/sta-pharmaceutical-switzerland-sa/db7f001f-c813-436e-9e88-2fb42e881820

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c